New study aims to fill knowledge gaps for Hard-to-Treat lymphoma patients
NCT ID NCT07335120
First seen Jan 12, 2026 · Last updated May 16, 2026 · Updated 21 times
Summary
This study gathers real-world data and samples from 800 people with large B-cell lymphoma who are either too frail for standard treatment or whose cancer returned after initial therapy. The goal is to learn how these patients are managed and what their outcomes are, which could guide future research and improve care. No new treatments are tested; instead, the study observes current practices.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DLBCL are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Clatterbridge Cancer Centre NHS Foundation Trust
RECRUITINGLiverpool, Merseyside, L78YA, United Kingdom
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.